Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Lantern Pharma Inc
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 200 billion oncology-focused data points and a library of 200+ ML algorithms. It is engaged in the development of its pipeline of drug candidates that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate program. Its portfolio includes a Phase II clinical program (LP-300) in NSCLC focused on never-smokers and non-smokers with the EGFR exon 21 L858R mutation; planned Phase I b/II trials (LP-184) in precision, biomarker-defined solid tumors, and an ongoing Phase II program in hematologic malignancies and adult soft tissue sarcomas (LP-284). It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.
Find out what a historical investment in Lantern Pharma Inc would be worth today using our LTRN stock calculator.
Market Capitalisation
$49.50M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
133.56K
High today
$4.12
Low today
$3.86
Open price
$4.05
52-week high
$5.74
52-week low
$1.11
Ready to start your investing journey with Stake?
Open an accountHow do I buy LTRN shares in Australia?
Buying LTRN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Lantern Pharma Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LTRN
What is the ticker symbol of Lantern Pharma Inc?
The ticker symbol for Lantern Pharma Inc is LTRN.
How much is one share of LTRN?
One share of LTRN is valued at $3.96 as of 13 June 2026.
What is the market capitalisation of Lantern Pharma Inc LTRN?
As of 13 June 2026 Lantern Pharma Inc has a market cap of $49.50M.
What is the 52-week high for Lantern Pharma Inc stock?
The Lantern Pharma Inc 52-week high stock price is $5.74.
What is the 52-week low for Lantern Pharma Inc stock?
The Lantern Pharma Inc 52-week low stock price is $1.11.
Can I buy LTRN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LTRN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LTRN on Stake
- Buy LTRN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LTRN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LTRN related stocks